Page last updated: 2024-08-23

selegiline and Depressive Disorder, Treatment-Resistant

selegiline has been researched along with Depressive Disorder, Treatment-Resistant in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Agapoff, JR; Goebert, D; Lu, BY; Olson, DJ; Roller, A; Williams, SR1

Other Studies

1 other study(ies) available for selegiline and Depressive Disorder, Treatment-Resistant

ArticleYear
Rapid and sustained improvement in treatment-refractory depression through use of acute intravenous ketamine and concurrent transdermal selegiline: A case series.
    Journal of affective disorders, 2020, 02-01, Volume: 262

    Topics: Administration, Cutaneous; Antidepressive Agents; Depressive Disorder, Treatment-Resistant; Drug Therapy, Combination; Female; Humans; Ketamine; Male; Middle Aged; Selegiline; Treatment Outcome

2020